Results and Data Sample Clauses

Results and Data. Provider shall inform the affected personnel of the results of each test performed within 48-72 hours from administering each test.
Sample 1Sample 2
AutoNDA by SimpleDocs
Results and Data. Provider shall inform all patients, the County, and the Xxxxxxxxxx County & Cities Health District of the results of each test performed.
Sample 1Sample 2
Results and Data. All Clinical Data shall be owned by the Party that conducts the applicable Clinical Trial. Without limiting the foregoing, any Clinical Data arising from the Initial Global Studies (other than the Novartis-Initiated Trials) and any New Registrational Clinical Trial and New Other Clinical Trial for which BeiGene is the Sponsoring Party and for which Novartis has provided a Novartis Study Design Agreement Notice (the “BeiGene Clinical Trial Data”) shall be owned by BeiGene and included in BeiGene Know-How and the Product Licenses granted to Novartis pursuant to Section 9.3.
Sample 1
Results and Data. Somanta shall be provided with, and shall have the right to access and use, all data collected or generated in the course of conducting the Clinical Trial, including, without limitation, records, reports, specimens, and other work product generated by or on behalf of any principal investigator in the course of performing the Clinical Trial, whether CONFIDENTIAL TREATMENT REQUESTED in written, graphic or electronic form or contained in any computer database or in any computer readable form ("Data"). CRICC agrees to attempt to require the principal investigator to ensure the accuracy, completeness, legibility and timeliness of all Data provided.
Sample 1
Results and Data. The data and test results of research and development conducted as a result of this Agreement are confidential, proprietary and of great value to the parties. The data and test results are subject to the terms of Article X of this Agreement which are not inconsistent with this Section 11.1. XXXXX XXXX shall not use or disclose the data or test results for any purpose other than in accordance with the terms of this Agreement. The data and test results shall be deemed to embody Technology. The data and test results shall be owned solely by ADOLOR, and ADOLOR shall be free to use the data and test results for any purpose, including but not limited to disclosure to a third party.
Sample 1
Results and Data. 9. Výsledky a údaje. Clinician Site and the Principal Investigator warrant that all CRFs submitted to Company will be complete and will accurately reflect the results of the Study. The parties acknowledge and agree that the data collected by Company in the performance of the Study shall be owned by Company or Sponsor, as agreed among themselves. Consistent with the terms of this Agreement, Company and Sponsor shall have the exclusive right to aggregate, deidentify and anonymize the data obtained from the Study performed pursuant to this Agreement. Clinician Site and the Principal Investigator shall have no rights in the results and data. Clinician Site shall be solely responsible for all payments due to the Principal Investigator and/or Clinician Site’s employees and/or collaborators according to the applicable law for any inventions transferred to Company or Sponsor or their designee. In any case, all data, information and documents provided to Clinician Site and the Principal Investigator by Company or Sponsor or any of their affiliates, whether in paper, oral, electronic or other form, shall remain the sole property of Company or Sponsor (and/or their affiliates), as the case may be. Klinické pracoviště a hlavní zkoušející ručí za to, že všechny záznamy subjektu hodnocení předložené společnosti budou úplné a budou přesně odrážet výsledky studie. Strany potvrzují a souhlasí s tím, že údaje shromážděné společností při provádění studie patří společnosti nebo zadavateli podle jejich vzájemné dohody. V souladu s podmínkami této smlouvy bude mít společnost a zadavatel výhradní právo k agregování, deidentifikování a anonymizování údajů získaných ze studie provedené podle této smlouvy. Klinické pracoviště a hlavní zkoušející nebudou mít žádná práva související s výsledky a údaji. Výhradní odpovědnost za všechny platby ve prospěch hlavního zkoušejícího a/nebo zaměstnanců či spolupracovníků klinického pracoviště v souladu s platnými právními předpisy nese za jakékoliv vynálezy převedené společnosti nebo zadavateli nebo jimi pověřené osobě klinické pracoviště. V každém případě zůstanou všechny údaje, informace a dokumenty poskytnuté klinickému pracovišti a hlavnímu zkoušejícímu společností nebo zadavatelem nebo přidruženými stranami, ať už písemně, ústně, elektronicky nebo jinak, výhradním majetkem společnosti nebo zadavatele (a/nebo přidružených stran), podle jejich povahy.
Sample 1
Results and Data. All Clinical Data shall be owned by the Party that conducts the applicable Clinical Trial. Without limiting the foregoing, any Clinical Data arising from the BeiGene Ongoing Clinical Trials (the “BeiGene Ongoing Clinical Trial Data”) shall be owned by BeiGene and included in BeiGene Know-How and the licenses granted to Novartis pursuant to Section 9.1.
Sample 1
AutoNDA by SimpleDocs
Results and Data. Somanta shall be provided with, and shall have the right to access and use, all data collected or generated in the course of conducting the Clinical Trial, including, without limitation, records, reports, specimens, and other work product generated by or on behalf of any principal investigator in the course of performing the Clinical Trial, whether in written, graphic or electronic form or contained in any computer database or in any computer readable form (“Data”). CRICC agrees to attempt to require the principal investigator to ensure the accuracy, completeness, legibility and timeliness of all Data provided. CONFIDENTIAL TREATMENT REQUESTED
Sample 1

Related to Results and Data

  • INFORMATION AND DATA 21.1 At all times during the subsistence of this Agreement the duly authorized representatives of each Participant shall, at its and their sole risk and expense and at reasonable intervals and times, have access to the Property and to all technical records and other factual engineering data and information relating to the Property which is in the possession of the Operator.

  • Books, Records and Regulatory Filings (a) The Sub-Adviser agrees to maintain and to preserve for the applicable periods any such records as are required to be maintained by the Sub-Adviser with respect to the Fund by the 1940 Act and rules adopted thereunder, and by any other applicable laws, rules and regulations. The Sub-Adviser further agrees that all records that it maintains for the Fund are the property of the Fund and it will promptly surrender any of such records upon request; provided, however, that the Sub-Adviser may retain copies of such records for the applicable periods they are required by law to be retained, and thereafter shall destroy such records.

  • Inspection of Property; Books and Records; Discussions Keep proper books of records and account in which full, true and correct entries in conformity with GAAP and all Requirements of Law shall be made of all dealings and transactions in relation to its business and activities; and permit representatives of any Lender (upon reasonable advance notice coordinated through the Administrative Agent) to visit and inspect any of its properties and examine and make abstracts from any of its books and records at any reasonable time and as often as may reasonably be desired and to discuss the business, operations, properties and financial and other condition of the Borrower and its Subsidiaries with officers and employees of the Borrower and its Subsidiaries and with its independent certified public accountants.

  • Background Data The Disclosing Party's Background Data, if any, will be identified in a separate technical document.

  • Data To permit evaluation of requests under paragraph (c) of this clause based on unreasonable cost, the Contractor shall include the following information and any applicable supporting data based on the survey of suppliers: Foreign and Domestic Construction Materials Cost Comparison Construction material description Unit of measure Quantity Cost (dollars) * Item 1: Foreign construction material Domestic construction material Item 2 Foreign construction material Domestic construction material [List name, address, telephone number, and contact for suppliers surveyed. Attach copy of response; if oral, attach summary.] [Include other applicable supporting information.] (*Include all delivery costs to the construction site.]

  • Other Data The statistical, industry-related and market-related data included in the Registration Statement, the Statutory Prospectus and the Prospectus, if any, are based on or derived from sources that the Company reasonably and in good faith believes are reliable and accurate, and such data agree with the sources from which they are derived.

  • How to Update Your Records You agree to promptly update your registration records if your e-mail address or other information changes. You may update your records, such as your e-mail address, by using the Profile page.

  • Reports and Records The Custodian shall:

  • SERVICE MONITORING, ANALYSES AND ORACLE SOFTWARE 11.1 We continuously monitor the Services to facilitate Oracle’s operation of the Services; to help resolve Your service requests; to detect and address threats to the functionality, security, integrity, and availability of the Services as well as any content, data, or applications in the Services; and to detect and address illegal acts or violations of the Acceptable Use Policy. Oracle monitoring tools do not collect or store any of Your Content residing in the Services, except as needed for such purposes. Oracle does not monitor, and does not address issues with, non-Oracle software provided by You or any of Your Users that is stored in, or run on or through, the Services. Information collected by Oracle monitoring tools (excluding Your Content) may also be used to assist in managing Oracle’s product and service portfolio, to help Oracle address deficiencies in its product and service offerings, and for license management purposes.

  • Books and Records Reports (a) The Trustees shall keep a certified copy or duplicate original of this Trust Agreement on file at the office of the Trust and the office of the Administrator available for inspection at all reasonable times during its usual business hours by any Holder. The Trustees shall keep proper books of record and account for all the transactions under this Trust Agreement at the office of the Trust and the office of the Administrator, and such books and records shall be open to inspection by any Holder at all reasonable times during usual business hours. The Trustees shall retain all books and records in compliance with Section 31 of the Investment Company Act and the rules and regulations thereunder.

Time is Money Join Law Insider Premium to draft better contracts faster.